These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38112136)

  • 1. [Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)].
    ; ; ; ; ; ; ; ; ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Dec; 25(12):1198-1210. PubMed ID: 38112136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease.
    ; ; ; ; ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Sept 15; 23(9):867-876. PubMed ID: 34535199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of Kawasaki disease].
    Bajolle F
    Rev Prat; 2023 Feb; 73(2):179-186. PubMed ID: 36916262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease.
    Sundel RP
    Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.
    ; ; ; ; ; ; ; ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):225-231. PubMed ID: 35351250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China.
    Jiao F; Pan Y; Du Z; Deng F; Yang X; Wang H; Shen J; Xiang W; Mu Z; Gao C; Bai J
    BMC Pediatr; 2024 Jul; 24(1):477. PubMed ID: 39060924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki Disease: Issues in Diagnosis and Treatment--A Developing Country Perspective.
    Singh S; Sharma A; Jiao F
    Indian J Pediatr; 2016 Feb; 83(2):140-5. PubMed ID: 26400032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.
    Sadeghi P; Izadi A; Mojtahedi SY; Khedmat L; Jafari M; Afshin A; Yarahmadi P; Hosseinali Beigi E
    BMC Infect Dis; 2021 Apr; 21(1):368. PubMed ID: 33874899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pediatric expert consensus on the application of aspirin in Kawasaki disease].
    ; ; ; ; ; ; ; ; ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):597-603. PubMed ID: 35652428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids for the treatment of Kawasaki disease in children.
    Wardle AJ; Connolly GM; Seager MJ; Tulloh RM
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011188. PubMed ID: 28129459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.
    Stasiak A; Smolewska E
    Rheumatol Int; 2019 Jun; 39(6):1069-1076. PubMed ID: 30903369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of Kawasaki disease in Polish children: A retrospective study.
    Smorczewska-Kiljan A; Marszał M; Friedman-Gruszczyńska J; Wieteska-Klimczak A; Książyk J; Jaworski M; Buda P
    Kardiol Pol; 2022; 80(6):657-663. PubMed ID: 35380006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State-of-the-art acute phase management of Kawasaki disease after 2017 scientific statement from the American Heart Association.
    Liu YC; Lin MT; Wang JK; Wu MH
    Pediatr Neonatol; 2018 Dec; 59(6):543-552. PubMed ID: 29706362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki disease fact check: Myths, misconceptions and mysteries.
    Butters C; Curtis N; Burgner DP
    J Paediatr Child Health; 2020 Sep; 56(9):1343-1345. PubMed ID: 32770807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L; Zhang J; Zhong J; Zheng Y
    J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K
    J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Distinct Cases of Adult-onset Kawasaki Disease.
    Onoki T; Metoki T; Iwasawa S; Kawano K; Kimura M; Kure S; Ota C
    Intern Med; 2022 Dec; 61(23):3525-3529. PubMed ID: 35466164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute phase of Kawasaki disease: a review of national guideline recommendations.
    Scherler L; Haas NA; Tengler A; Pattathu J; Mandilaras G; Jakob A
    Eur J Pediatr; 2022 Jul; 181(7):2563-2573. PubMed ID: 35403975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease shock syndrome: a rare and severe complication of Kawasaki disease.
    Çakan M; Gemici H; Aktay-Ayaz N; Keskindemirci G; Bornaun H; İkizoğlu T; Çeliker A
    Turk J Pediatr; 2016; 58(4):415-418. PubMed ID: 28276216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.